These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 8816843
1. Squamous cell carcinoma-associated antigens used in novel strategies for the detection and treatment of minimal residual head and neck cancer. van Dongen GA, Brakenhoff RM, ten Brink CT, van Gog FB, de Bree R, Quak JJ, Snow GB. Anticancer Res; 1996; 16(4C):2409-13. PubMed ID: 8816843 [Abstract] [Full Text] [Related]
2. Clinical significance of micrometastatic cells detected by E48 (Ly-6D) reverse transcription-polymerase chain reaction in bone marrow of head and neck cancer patients. Colnot DR, Nieuwenhuis EJ, Kuik DJ, Leemans CR, Dijkstra J, Snow GB, van Dongen GA, Brakenhoff RH. Clin Cancer Res; 2004 Dec 01; 10(23):7827-33. PubMed ID: 15585614 [Abstract] [Full Text] [Related]
6. PET monitoring of therapy response in head and neck squamous cell carcinoma. Schöder H, Fury M, Lee N, Kraus D. J Nucl Med; 2009 May 01; 50 Suppl 1():74S-88S. PubMed ID: 19380408 [Abstract] [Full Text] [Related]
8. Radioimmunotherapy with astatine-211 using chimeric monoclonal antibody U36 in head and neck squamous cell carcinoma. Cheng J, Ekberg T, Engström M, Nestor M, Jensen HJ, Tolmachev V, Anniko M. Laryngoscope; 2007 Jun 01; 117(6):1013-8. PubMed ID: 17440426 [Abstract] [Full Text] [Related]
9. Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy. Tan A, Adelstein DJ, Rybicki LA, Saxton JP, Esclamado RM, Wood BG, Lorenz RR, Strome M, Carroll MA. Arch Otolaryngol Head Neck Surg; 2007 May 01; 133(5):435-40. PubMed ID: 17515501 [Abstract] [Full Text] [Related]
10. [Current trends in diagnosis and treatment head and neck cancer]. Lacau St Guily JL. Rev Prat; 2006 Oct 15; 56(15):1652-7. PubMed ID: 17137249 [Abstract] [Full Text] [Related]
11. Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients. Börjesson PK, Jauw YW, Boellaard R, de Bree R, Comans EF, Roos JC, Castelijns JA, Vosjan MJ, Kummer JA, Leemans CR, Lammertsma AA, van Dongen GA. Clin Cancer Res; 2006 Apr 01; 12(7 Pt 1):2133-40. PubMed ID: 16609026 [Abstract] [Full Text] [Related]
13. Radioimmunoscintigraphy and biodistribution of technetium-99m-labeled monoclonal antibody U36 in patients with head and neck cancer. de Bree R, Roos JC, Quak JJ, den Hollander W, Snow GB, van Dongen GA. Clin Cancer Res; 1995 Jun 01; 1(6):591-8. PubMed ID: 9816020 [Abstract] [Full Text] [Related]
14. Phase I therapy study of 186Re-labeled chimeric monoclonal antibody U36 in patients with squamous cell carcinoma of the head and neck. Colnot DR, Quak JJ, Roos JC, van Lingen A, Wilhelm AJ, van Kamp GJ, Huijgens PC, Snow GB, van Dongen GA. J Nucl Med; 2000 Dec 01; 41(12):1999-2010. PubMed ID: 11138685 [Abstract] [Full Text] [Related]
15. Molecular assay to detect metastatic head and neck squamous cell carcinoma. Becker MT, Shores CG, Yu KK, Yarbrough WG. Arch Otolaryngol Head Neck Surg; 2004 Jan 01; 130(1):21-7. PubMed ID: 14732763 [Abstract] [Full Text] [Related]
20. Role of squamous cell carcinoma antigen 1 expression in the invasive potential of head and neck squamous cell carcinoma. Nakashima T, Yasumatsu R, Kuratomi Y, Masuda M, Kuwano T, Toh S, Umezaki T, Cataltepe S, Silverman GA, Komune S. Head Neck; 2006 Jan 01; 28(1):24-30. PubMed ID: 16155915 [Abstract] [Full Text] [Related] Page: [Next] [New Search]